SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-018241
Filing Date
2016-11-10
Accepted
2016-11-10 17:29:36
Documents
56
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0916_soligenixinc.htm 10-Q 547745
2 CERTIFICATION f10q0916ex31i_soligenixinc.htm EX-31.1 17781
3 CERTIFICATION f10q0916ex31ii_soligenixinc.htm EX-31.2 16560
4 CERTIFICATION f10q0916ex32i_soligenixinc.htm EX-32.1 4780
5 CERTIFICATION f10q0916ex32ii_soligenixinc.htm EX-32.2 5550
  Complete submission text file 0001213900-16-018241.txt   3324434

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20160930.xml EX-101.INS 593772
7 XBRL SCHEMA FILE sngx-20160930.xsd EX-101.SCH 34260
8 XBRL CALCULATION FILE sngx-20160930_cal.xml EX-101.CAL 33745
9 XBRL DEFINITION FILE sngx-20160930_def.xml EX-101.DEF 124401
10 XBRL LABEL FILE sngx-20160930_lab.xml EX-101.LAB 343939
11 XBRL PRESENTATION FILE sngx-20160930_pre.xml EX-101.PRE 223480
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 161989284
SIC: 2834 Pharmaceutical Preparations